VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.37M | 2.33M | 2.68M | 3.28M | 4.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73M | 2.88M | 3.29M | 4.14M | 5.74M |
| Operating Income | -2.73M | -2.88M | -3.29M | -4.14M | -5.74M |
| Income Before Tax | -4.33M | -4.38M | -4.98M | -6.22M | -8.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.33 | -4.38 | -4.98 | -6.22 | -8.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 34.40K | 34.40K | 34.40K | 34.40K | 53.60K |
| Net Income | -4.30M | -4.35M | -4.95M | -6.19M | -8.84M |
| EBIT | -2.73M | -2.88M | -3.29M | -4.14M | -5.74M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.07 | -0.10 | -0.16 | -0.28 | -0.49 |
| Normalized Basic EPS | -0.04 | -0.06 | -0.10 | -0.17 | -0.31 |
| EPS Diluted | -0.07 | -0.10 | -0.16 | -0.28 | -0.49 |
| Normalized Diluted EPS | -0.04 | -0.06 | -0.10 | -0.17 | -0.31 |
| Average Basic Shares Outstanding | 242.56M | 186.05M | 141.93M | 109.16M | 84.29M |
| Average Diluted Shares Outstanding | 242.56M | 186.05M | 141.93M | 109.16M | 84.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
